IEIIS Meeting minireview: The role of innate immunity in the pathogenesis of asthma: Evidence for the involvement of Toll-like receptor signaling

Journal of Endotoxin Research

Volumn 13, Issue 5, 2007, Pages 305-312

  Schröder, Nicolas W J ^a   Arditi, Moshe ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b CEDARS SINAI MEDICAL CENTER   (United States)

Author keywords

Allergy; Asthma; Endotoxin; Mouse models; Polymorphisms; Toll like receptors

Indexed keywords

ANTIBIOTIC AGENT; CPG OLIGODEOXYNUCLEOTIDE; TOLL LIKE RECEPTOR; LIGAND; VACCINE;

ALLERGIC ASTHMA; ANTIGEN SPECIFICITY; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE PREDISPOSITION; DISEASE SEVERITY; EVIDENCE BASED MEDICINE; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOGENESIS; IMMUNOTHERAPY; INFECTION; INNATE IMMUNITY; MONOTHERAPY; NONHUMAN; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SENSITIZATION; ANIMAL; ASTHMA; DISEASE MODEL; GENETICS; IMMUNOLOGY; MICROBIOLOGY; MOUSE; REVIEW; SIGNAL TRANSDUCTION;

MUS;

ANIMALS; ASTHMA; DISEASE MODELS, ANIMAL; HUMANS; IMMUNITY, NATURAL; LIGANDS; MICE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS; VACCINES;

EID: 35848967805     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/0968051907084652     Document Type: Conference Paper

References (90)

1. Eder W., Ege MJ, von Mutius E. The asthma epidemic. N Engl J Med 2006; 355: 2226-2235.
2. Beasley R., Crane J., Lai CK, Pearce N. Prevalence and etiology of asthma. J Allergy Clin Immunol 2000; 105: S466-S472.
3. Strachan DP Hay fever, hygiene, and household size. BMJ 1989; 299: 1259-1260.
4. Strachan DP Family size, infection and atopy: The first decade of the 'hygiene hypothesis'. Thorax 2000; 55 (Suppl 1): S2-S10.
5. von Mutius E., Pearce N., Beasley R. et al. International patterns of tuberculosis and the prevalence of symptoms of asthma, rhinitis, and eczema. Thorax 2000; 55: 449-453.
6. McIntire JJ, Umetsu SE, Akbari O. et al. Identification of Tapr (an airway hyperreactivity regulatory locus) and the linked Tim gene family. Nat Immunol 2001; 2: 1109-1116.
7. Gereda JE, Leung DY, Thatayatikom A. et al. Relation between house-dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet 2000; 355: 1680-1683.
8. Braun-Fahrlander C., Riedler J., Herz U. et al. Environmental exposure to endotoxin and its relation to asthma in school-age children. N Engl J Med 2002; 347: 869-877.
9. Johnston SL, Martin RJ Chlamydophila pneumoniae and Mycoplasma pneumoniae: A role in asthma pathogenesis? Am J Respir Crit Care Med 2005; 172: 1078-1089.
10. Murray CS, Simpson A., Custovic A. Allergens, viruses, and asthma exacerbations. Proc Am Thorac Soc 2004; 1: 99-104.
11. Gern JE, Busse WW Relationship of viral infections to wheezing illnesses and asthma. Nat Rev Immunol 2002; 2: 132-138.
12. Hahn DL, Dodge RW, Golubjatnikov R. Association of Chlamydia pneumoniae (strain TWAR) infection with wheezing, asthmatic bronchitis, and adult-onset asthma. JAMA 1991; 266: 225-230.
13. Sirmatel F., Ustunsoy H., Sirmatel O., Akdemir I., Dikensoy O. The relationship between Chlamydia pneumoniae seropositivity and peripheral vascular diseases, acute myocardial infarction and late-onset asthma. Infection 2003; 31: 367-368.
14. Normann E., Gnarpe J., Wettergren B., Janson C., Wickman M., Nordvall L. The association between Chlamydia pneumoniae antibodies and wheezing in young children and the influence of sex. Thorax 2006; 61: 1054-1058.
15. Eldridge MW, Peden DB Allergen provocation augments endotoxin-induced nasal inflammation in subjects with atopic asthma. J Allergy Clin Immunol 2000; 105: 475-481.
16. Park JH, Gold DR, Spiegelman DL, Burge HA, Milton DK House dust endotoxin and wheeze in the first year of life. Am J Respir Crit Care Med 2001; 163: 322-328.
17. Medzhitov R. Toll-like receptors and innate immunity. Nat Rev Immunol 2001; 1: 135-145.
18. Uematsu S., Akira S. Toll-like receptors and innate immunity. J Mol Med 2006; 84: 712-725.
19. Hoebe K., Janssen EM, Kim SO et al. Upregulation of costimulatory molecules induced by lipopolysaccharide and double-stranded RNA occurs by Trif-dependent and Trifindependent pathways. Nat Immunol 2003; 4: 1223-1229.
20. Beutler B. The Toll-like receptors: Analysis by forward genetic methods. Immunogenetics 2005; 57: 385-392.
21. Kawai T., Akira S. TLR signaling. Semin Immunol 2007; 19: 24-32.
22. Yamamoto M., Sato S., Hemmi H. et al. TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway. Nat Immunol 2003; 4: 1144-1150.
23. Yamamoto M., Sato S., Hemmi H. et al. Role of adaptor TRIF in the MyD88-independent Toll-like receptor signaling pathway. Science 2003; 301: 640-643.
24. Hoebe K., Du X., Georgel P. et al. Identification of Lps2 as a key transducer of MyD88-independent TIR signalling. Nature 2003; 424: 743-748.
25. Kawai T., Sato S., Ishii KJ et al. Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6. Nat Immunol 2004; 5: 1061-1068.
26. Schroder NW, Schumann RR Single nucleotide polymorphisms of Toll-like receptors and susceptibility to infectious disease. Lancet Infect Dis 2005; 5: 156-164.
27. Arbour NC, Lorenz E., Schutte BC et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25: 187-191.
28. Raby BA, Klimecki WT, Laprise C. et al. Polymorphisms in Toll-like receptor 4 are not associated with asthma or atopy-related phenotypes. Am J Respir Crit Care Med 2002; 166: 1449-1456.
29. Yang IA, Barton SJ, Rorke S. et al. Toll-like receptor 4 polymorphism and severity of atopy in asthmatics. Genes Immun 2004; 5: 41-45.
30. Adjers K., Karjalainen J., Pessi T., Eklund C., Hurme M. Epistatic effect of TLR4 and IL4 genes on the risk of asthma in females. Int Arch Allergy Immunol 2005; 138: 251-256.
31. Sackesen C., Karaaslan C., Keskin O. et al. The effect of polymorphisms at the CD14 promoter and the TLR4 gene on asthma phenotypes in Turkish children with asthma. Allergy 2005; 60: 1485-1492.
32. Eder W., von Mutius E. Genetics in asthma: The solution to a lasting conundrum? Allergy 2005; 60: 1482-1484.
33. Tantisira K., Klimecki WT, Lazarus R. et al. Toll-like receptor 6 gene (TLR6): Single-nucleotide polymorphism frequencies and preliminary association with the diagnosis of asthma. Genes Immun 2004; 5: 343-346.
34. Lauener RP, Birchler T., Adamski J. et al. Expression of CD14 and Toll-like receptor 2 in farmers' and non-farmers' children. Lancet 2002; 360: 465-466.
35. Riedler J., Braun-Fahrlander C., Eder W. et al. Exposure to farming in early life and development of asthma and allergy: A cross-sectional survey. Lancet 2001; 358: 1129-1133.
36. Matsuguchi T., Musikacharoen T., Ogawa T., Yoshikai Y. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced by LPS and inflammatory cytokines in mouse macrophages. J Immunol 2000; 165: 5767-5772.
37. Poltorak A., He X., Smirnova I. et al. Defective LPS signaling in C3H/ HeJ and C57BL/10ScCr mice: Mutations in Tlr4 gene. Science 1998; 282: 2085-2088.
38. Dabbagh K., Dahl ME, Stepick-Biek P., Lewis DB Toll-like receptor 4 is required for optimal development of Th2 immune responses: Role of dendritic cells. J Immunol 2002; 168: 4524-4530.
39. Eisenbarth SC, Piggott DA, Huleatt JW, Visintin I, Herrick CA, Bottomly K. Lipopolysaccharide-enhanced, Toll-like receptor 4-dependent T helper cell type 2 responses to inhaled antigen. J Exp Med 2002; 196: 1645-1651.
40. Piggott DA, Eisenbarth SC, Xu L. et al. MyD88-dependent induction of allergic Th2 responses to intranasal antigen. J Clin Invest 2005; 115: 459-467.
41. Nigo YI, Yamashita M., Hirahara K. et al. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function. Proc Natl Acad Sci USA 2006; 103: 2286-2291.
42. Agrawal S., Agrawal A., Doughty B. et al. Different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 2003; 171: 4984-4989.
43. Constant SL, Lee KS, Bottomly K. Site of antigen delivery can influence T cell priming: Pulmonary environment promotes preferential Th2-type differentiation. Eur J Immunol 2000; 30: 840-847.
44. Redecke V., Hacker H., Datta SK et al. Activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004; 172: 2739-2743.
45. Sel S., Wegmann M., Sel S. et al. Immunomodulatory effects of viral TLR ligands on experimental asthma depend on the additive effects of IL-12 and IL-10. J Immunol 2007; 178: 7805-7813.
46. Michel O., Kips J., Duchateau J. et al. Severity of asthma is related to endotoxin in house dust. Am J Respir Crit Care Med 1996; 154: 1641-1646.
47. Schwartz DA, Thorne PS, Yagla SJ et al. The role of endotoxin in grain dust-induced lung disease. Am J Respir Crit Care Med 1995; 152: 603-608.
48. Rodriguez D., Keller AC, Faquim-Mauro EL et al. Bacterial lipopolysaccharide signaling through Toll-like receptor 4 suppresses asthma-like responses via nitric oxide synthase 2 activity. J Immunol 2003; 171: 1001-1008.
49. Hollingsworth JW, Whitehead GS, Lin KL et al. TLR4 signaling attenuates ongoing allergic inflammation. J Immunol 2006; 176: 5856-5862.
50. Revets H., Pynaert G., Grooten J., De Baetselier P. Lipoprotein I, a TLR2/4 ligand modulates Th2-driven allergic immune responses. J Immunol 2005; 174: 1097-1103.
51. Jung YW, Schoeb TR, Weaver CT, Chaplin DD Antigen and lipopolysaccharide play synergistic roles in the effector phase of airway inflammation in mice. Am J Pathol 2006; 168: 1425-1434.
52. Yamamoto K., Kawamura I., Ito J., Mitsuyama M. Modification of allergic inflammation in murine model of rhinitis by different bacterial ligands: involvement of mast cells and dendritic cells. Clin Exp Allergy 2006; 36: 760-769.
53. Mallia P., Johnston SL How viral infections cause exacerbation of airway diseases. Chest 2006; 130: 1203-1210.
54. Martin RJ Infections and asthma. Clin Chest Med 2006; 27: 87-98, vi.
55. Dahl ME, Dabbagh K., Liggitt D., Kim S., Lewis DB Viral-induced T helper type 1 responses enhance allergic disease by effects on lung dendritic cells. Nat Immunol 2004; 5: 337-343.
56. Marsland BJ, Kopf M., Le Gros G. Viral infection and allergy. Nat Immunol 2004; 5: 865; author reply 865-866.
57. Marsland BJ, Scanga CB, Kopf M., Le Gros G. Allergic airway inflammation is exacerbated during acute influenza infection and correlates with increased allergen presentation and recruitment of allergen-specific T-helper type 2 cells. Clin Exp Allergy 2004; 34: 1299-1306.
58. Michelsen KS, Aicher A., Mohaupt M. et al. The role of Toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCS). Peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J Biol Chem 2001; 276: 25680-25686.
59. Schnare M., Barton GM, Holt AC, Takeda K., Akira S., Medzhitov R. Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2001; 2: 947-950.
60. Pauligk C., Nain M., Reiling N., Gemsa D., Kaufmann A. CD14 is required for influenza A virus-induced cytokine and chemokine production. Immunobiology 2004; 209: 3-10.
61. Marshall-Clarke S., Tasker L., Buchatska O. et al. Influenza H2 haemagglutinin activates B cells via a MyD88-dependent pathway. Eur J Immunol 2006; 36: 95-106.
62. Gerhold K., Blumchen K., Bock A. et al. Endotoxins prevent murine IgE production, T(H)2 immune responses, and development of airway eosinophilia but not airway hyperreactivity. J Allergy Clin Immunol 2002; 110: 110-116.
63. Gerhold K., Bluemchen K., Franke A., Stock P., Hamelmann E. Exposure to endotoxin and allergen in early life and its effect on allergen sensitization in mice. J Allergy Clin Immunol 2003; 112: 389-396.
64. Wang Y., McCusker C. Neonatal exposure with LPS and/or allergen prevents experimental allergic airways disease: Development of tolerance using environmental antigens. J Allergy Clin Immunol 2006; 118: 143-151.
65. Gerhold K., Avagyan A., Seib C. et al. Prenatal initiation of endotoxin airway exposure prevents subsequent allergen-induced sensitization and airway inflammation in mice. J Allergy Clin Immunol 2006; 118: 666-673.
66. Lin W., Truong N., Grossman WJ et al. Allergic dysregulation and hyperimmunoglobulinemia E in Foxp3 mutant mice. J Allergy Clin Immunol 2005; 116: 1106-1115.
67. Akdis M., Verhagen J., Taylor A. et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med 2004; 199: 1567-1575.
68. Akdis CA, Blesken T., Akdis M., Wuthrich B., Blaser K. Role of interleukin 10 in specific immunotherapy. J Clin Invest 1998; 102: 98-106.
69. Lewkowich IP, Herman NS, Schleifer KW et al. CD4+CD25+ T cells protect against experimentally induced asthma and alter pulmonary dendritic cell phenotype and function. J Exp Med 2005; 202: 1549-1561.
70. Sutmuller RP, den Brok MH, Kramer M. et al. Toll-like receptor 2 controls expansion and function of regulatory T cells. J Clin Invest 2006; 116: 485-494.
71. Liu H., Komai-Koma M., Xu D., Liew FY Toll-like receptor 2 signaling modulates the functions of CD4+ CD25+ regulatory T cells. Proc Natl Acad Sci USA 2006; 103: 7048-7053.
72. Tsitoura DC, Blumenthal RL, Berry G., Dekruyff RH, Umetsu DT Mechanisms preventing allergen-induced airways hyperreactivity: Role of tolerance and immune deviation. J Allergy Clin Immunol 2000; 106: 239-246.
73. Akbari O., DeKruyff RH, Umetsu DT Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nat Immunol 2001; 2: 725-731.
74. Watanabe J., Miyazaki Y., Zimmerman GA, Albertine KH, McIntyre TM Endotoxin contamination of ovalbumin suppresses murine immunologic responses and development of airway hyper-reactivity. J Biol Chem 2003; 278: 42361-42368.
75. Stock P., Akbari O., Berry G., Freeman GJ, Dekruyff RH, Umetsu DT Induction of T helper type 1-like regulatory cells that express Foxp3 and protect against airway hyper-reactivity. Nat Immunol 2004; 5: 1149-1156.
76. den Haan JM, Kraal G., Bevan MJ Lipopolysaccharide induces IL-10-producing regulatory CD4+ T cells that suppress the CD8+ T cell response. J Immunol 2007; 178: 5429-5433.
77. Spiegelberg HL, Broide D., Tighe H., Roman M., Raz E. Inhibition of allergic inflammation in the lung by plasmid DNA allergen immunization. Pediatr Pulmonol Suppl 1999; 18: 118-121.
78. Sparwasser T., Miethke T., Lipford G. et al. Bacterial DNA causes septic shock. Nature 1997; 386: 336-337.
79. Kline JN, Waldschmidt TJ, Businga TR et al. Modulation of airway inflammation by CpG oligodeoxynucleotides in a murine model of asthma. J Immunol 1998; 160: 2555-2559.
80. Jain VV, Kitagaki K., Businga T. et al. CpG-oligodeoxynucleotides inhibit airway remodeling in a murine model of chronic asthma. J Allergy Clin Immunol 2002; 110: 867-872.
81. Krieg AM Therapeutic potential of Toll-like receptor 9 activation. Nat Rev Drug Discov 2006; 5: 471-484.
82. Liu YJ IPC: Professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 2005; 23: 275-306.
83. Hartmann G., Marschner A., Viveros PR et al. CpG oligonucleotides induce strong humoral but only weak CD4+ T cell responses to protein antigens in rhesus macaques in vivo. Vaccine 2005; 23: 3310-3317.
84. Heikenwalder M., Polymenidou M., Junt T. et al. Lymphoid follicle destruction and immunosuppression after repeated CpG oligodeoxynucleotide administration. Nat Med 2004; 10: 187-192.
85. Creticos PS, Schroeder JT, Hamilton RG et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med 2006; 355: 1445-1455.
86. Simons FE, Shikishima Y., Van Nest G., Eiden JJ, HayGlass KT Selective immune redirection in humans with ragweed allergy by injecting Amb a 1 linked to immunostimulatory DNA. J Allergy Clin Immunol 2004; 113: 1144-1151.
87. Jain VV, Businga TR, Kitagaki K., George CL, O'Shaughnessy PT, Kline JN. Mucosal immunotherapy with CpG oligodeoxynucleotides reverses a murine model of chronic asthma induced by repeated antigen exposure. Am J Physiol 2003; 285: L1137-L1146.
88. Fanucchi MV, Schelegle ES, Baker GL et al. Immunostimulatory oligonucleotides attenuate airways remodeling in allergic monkeys. Am J Respir Crit Care Med 2004; 170: 1153-1157.
89. Papadopoulos NG, Psarras S., Manoussakis E., Saxoni-Papageorgiou P. The role of respiratory viruses in the origin and exacerbations of asthma. Curr Opin Allergy Clin Immunol 2003; 3: 39-44.
90. Papadopoulos NG, Kalobatsou A. Respiratory viruses in childhood asthma. Curr Opin Allergy Clin Immunol 2007; 7: 91-95.